Avalo Therapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 30 superinvestors own shares of Avalo Therapeutics Inc (AVTX), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Avalo Therapeutics Inc (AVTX), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Avalo Therapeutics Inc (AVTX) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Avalo Therapeutics Inc (AVTX) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
Superinvestor | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
Troy Wuertz@Ikarian Capital, Llc
| 1.29% | $9.218M 970,359 shares@ 9.51 avg price | Increased 1673% |
Michael Kramarz@Commodore Capital Lp
| 0.29% | $4.589M 483,000 shares@ 9.5 avg price | Increased 1107.5% |
Andrew Johnson@Ubs Group Ag
| 0.01% | $58,273 6,134 shares@ 9.5 avg price | Increased 71.2% |